S-2-Fmoc-amino-4-(1H-tetrazol-5-yl)butyric acid is a non-natural amino acid derivative featuring a tetrazole ring on its side chain. The tetrazole group serves as a bioisostere for a carboxylic acid, offering improved metabolic stability and altered physicochemical properties. The molecule is protected with an Fmoc (9-fluorenylmethoxycarbonyl) group on its alpha-amino function, making it directly compatible with standard Fmoc-based solid-phase peptide synthesis (SPPS) protocols. This building block is primarily used in medicinal chemistry and peptide research for the synthesis of peptide analogs and peptidomimetics. The incorporation of the tetrazole moiety can modulate the peptide's interaction with biological targets, such as receptors or enzymes, by mimicking a carboxylate while being resistant to enzymatic hydrolysis. It is particularly valuable for developing novel therapeutic peptides with enhanced pharmacokinetic profiles. As a specialized, protected amino acid, its application is highly focused on the synthesis of bioactive compounds for pharmaceutical research. It is not a commodity chemical or a general-purpose synthesis reagent. Proper handling requires standard laboratory safety precautions for fine chemicals.